CYTOKINETICS INC — Director's Dealing 2020

May 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-05-13

Reporting Person: SMITH SANDFORD D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-13	Non-Qualified Stock Option (right to buy)	$21.61	A	20000	Acquired	2030-05-13	Common Stock (20000)	Direct

Footnotes

F1: Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant.